Cue Biopharma share price logo

Cue Biopharma

NASDAQ: CUE

Small Cap

$30.50

+1.24

(+4.24%)

Live

as on

Cue Biopharma Stock Performance

as on May 14, 2026 at 5:11 am IST

  • Day's Low

    Day's High

    $27.28
    $30.64
    downward going graph

    10.56%

    Downside

    0.46%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.97
    $41.42
    downward going graph

    83.70%

    Downside

    35.80%

    Upside

    downward going graph

Cue Biopharma share price movements today

Previous Close
$29.26
Open
$29.68
Volume
244.3K
Day's Low - High
$27.28 - $30.64
52 Week Low - High
$4.97 - $41.42

Cue Biopharma Historical Returns

1 Month Return
+ 106.51 %
3 Month Return
+ 218.11 %
1 Year Return
+ 27.01 %
3 Year Return
-77.32 %
5 Year Return
-92.47 %

Cue Biopharma Stock Fundamentals & Key Indicators

Check Cue Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$95.3M

EPS (TTM)

-17.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-25.6M

Revenue (TTM)

27.5M

Profit Margin

-96.85%

Return On Equity TTM

-121.11%

Cue Biopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cue Biopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Cue Biopharma image
Cue Biopharma
BUY$95.3M-92.47%NA-96.85%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B119.7%71.3912.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B109.14%25.8435.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for Cue Biopharma Stock including INR - Dollar returns

The Cue Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Cue Biopharma investment value today

Current value as on today

₹1,48,571

Returns

₹48,571

(+48.57%)

Returns from Cue Biopharma Stock

₹32,378 (+32.38%)

Dollar Impact

₹16,192 (+16.19%)

Analyst Recommendation on Cue Biopharma Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Cue Biopharma. Average target price of $115

Cue Biopharma Share Price Target

Get share price movements and forecasts by analysts on Cue Biopharma.

What analysts predicted

73.48%UPSIDE

Target Price

$115

Current Price

$30.5

Analyzed by

9 Analysts

Target

$115.00

Cue Biopharma target price $115, a slight upside of 73.48% compared to current price of $30.5. According to 9 analysts rating.

Indian Investors' Interest in Cue Biopharma Stock

Investment in Cue Biopharma Shares on INDmoney has grown by 197.27% in the last 30 days, indicating increased investment activity.

Time period: to

Change:197.27% versus previous 30 day period

Search interest for Cue Biopharma Stock has increased by 1167% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1167% versus previous 30 day period

Cue Biopharma Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2
1
1
2
3
1
0
2
2
21
Gross Profit
-6
-11
1
2
3
1
0
2
2
18
Operating Income
-11
-13
-12
-10
-8
-9
-12
-8
-7
1
EBITDA
-11
-13
-11
-9
-7
-9
-11
-7
-7
3
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
1
Income Before Tax
-11
-13
-12
-10
-8
-9
-12
-8
-7
2
Income Tax Expense
0
0
0
-
-8
-
-
-
-
0
Net Income
-11
-13
-12
-10
-8
-9
-12
-8
-7
1
Net Profit Margin
-524.05%
-737.73%
-719.10%
-382.66%
-259.59%
-602.54%
-2911.40%
-287.14%
-346.58%
7.22%

Cue Biopharma Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
1
3
3
14
1
5
9
27
Gross Profit
0
0
-27
3
-30
14
1
-32
9
23
Operating Income
-7
-23
-38
-36
-45
-43
-53
-52
-41
-26
EBITDA
-7
-22
-37
-31
-43
-45
-50
-46
-37
-23
Interest Expense
-
-
-
5
0
1
0
1
0
0
Depreciation
-
0
0
5
1
-1
1
3
2
3
Income Before Tax
-7
-23
-38
-36
-44
-43
-53
-50
-40
-26
Income Tax Expense
-
-
0
0
0
0
0
3
-40
0
Net Income
-7
-23
-38
-36
-44
-44
-53
-50
-40
-26
Net Profit Margin
0.00%
0.00%
-3411.53%
-1061.25%
-1419.79%
-295.56%
-4257.83%
-924.10%
-437.97%
-96.85%

Cue Biopharma Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-13
-12
-10
-8
-9
-12
-8
-7
1
Operating Cash Flow
-10
-9
-9
-7
-9
-8
-3
-9
-1
Investing Cash Flow
-
0
0
0
0
0
0
-6
7
Financing Cash Flow
4
2
-1
9
0
-1
17
0
9
Change in Cash
-6
-7
-11
2
-9
-9
14
-15
15

Cue Biopharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-23
-38
-36
-44
-44
-53
-50
-40
-26
Operating Cash Flow
-12
-26
-30
-32
-38
-41
-39
-36
-21
Investing Cash Flow
-1
-20
3
4
9
-24
25
0
0
Financing Cash Flow
62
4
50
58
19
53
11
10
26
Change in Cash
48
-42
23
30
-10
-12
-3
-26
4

Global Institutional Holdings in Cue Biopharma

Funds
Holdings
Bank of America Corp
0.21%
Northern Trust Corp
0.1%
Chicago Partners Investment Group LLC
0.09%
Catalytic Wealth RIA LLC
4.74%
Lion Point Capital, LP
2.26%
See all

Insights on Cue Biopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, CUE stock has moved up by 106.5%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.14M → 21.94M (in $), with an average increase of 90.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -12.25M → 1.58M (in $), with an average increase of 209.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 109.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 13.2%

About Cue Biopharma

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States. Its lead drug product candidate is the CUE-401, a bifunctional fusion protein designed to promote immune tolerance by inducing iTregs from Teff cells which is in preclinical trial; and CUE-501, a treatment of autoimmune disease via anti-viral T cell-mediated depletion of B cells. The company also develops CUE-101, which is in phase 1b clinical trial to treat HPV+ recurrent metastatic, or head and neck squamous cell carcinoma in second line, and beyond patients as a monotherapy, as well as in phase 1b clinical trial for the treatment of head and neck squamous cell carcinoma as a first line, therapy in combination with standard of care KEYTRUDA; and CUE-102, which is in phase 1b clinical trial as a monotherapy in late line recurrent metastatic WT1+ colorectal, gastric, ovarian, and pancreatic cancer. It has collaboration agreements with LG Chem, Ltd. for the development of CUE-101 and CUE-102 Immuno-STATs; collaboration and option agreement with Ono Pharmaceutical Co., Ltd to development and commercialization rights for CUE-401; and license agreement with Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.
OrganisationCue Biopharma
Headquarters40 Guest Street, Boston, MA, United States, 02135
IndustryBiotechnology
CEODr. Shao-Lee Lin M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Cue Biopharma

Name

Title

Ms. Lucinda Warren

Principal Fin & Accounting Off. and Chief Financial & Business Officer

Mr. Colin G. Sandercock J.D., MSE

Senior VP, General Counsel & Secretary

Dr. Shao-Lee Lin M.D., Ph.D.

President, CEO & Director

Dr. Ronald D. Seidel III, Ph.D.

Co-Founder

Dr. Rodolfo Jose Chaparro Ph.D.

Co-Founder

Dr. Steven C. Almo Ph.D.

Co-Founder and Chairman of Scientific & Clinical Advisory Board

Dr. Daniel G. Baker M.D., Ph.D.

Interim Chief Development Officer

FAQs

What is Cue Biopharma share price today?

Cue Biopharma share price today is $30.5 as on . Cue Biopharma share today touched a day high of $30.64 and a low of $27.28.

What is the 52 week high and 52 week low for Cue Biopharma share?

Cue Biopharma share touched a 52 week high of $41.42 on and a 52 week low of $4.97 on . Cue Biopharma stock price today i.e. is trending at $30.5,which is 26.36% down from its 52 week high and 513.56% up from its 52 week low.

What is Cue Biopharma's market capitalisation today?

Cue Biopharma market capitalisation is $0.00T as on .

How to invest in Cue Biopharma Stock (CUE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cue Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cue Biopharma Shares that will get you 0.0492 shares as per Cue Biopharma share price of $30.5 per share as on May 13, 2026 at 11:41 pm IST.

What is the minimum amount required to buy Cue Biopharma Stock (CUE) from India?

Indian investors can start investing in Cue Biopharma (CUE) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Cue Biopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Cue Biopharma share’s latest price of $30.5 as on May 13, 2026 at 11:41 pm IST, you will get 0.3279 shares of Cue Biopharma. Learn more about fractional shares .

What are the returns that Cue Biopharma has given to Indian investors in the last 5 years?

Cue Biopharma stock has given -92.47% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?